Prabhudas Lilladhar
Online pharmacy startup PharmEasy announced acquisition of THYROCARE Technologies, with a view to add diagnostic services in its digital offerings through biochemistry/pathology business. PharmEasy's parent company API...
Thyrocare Technologi.. has an average target of 1560.00 from 1 broker.
More from Thyrocare Technologies Ltd.
Recommended